Navigation Links
Atripla in Medical News

Specialists are Highly Satisfied with the Safety and Efficacy of Atripla and Isentress in the Treatment of HIV Patients

A CCR5 Antagonist That is Dosed Once Daily Could Earn an 18 Percent Patient Share in the U.S. and a 30 Percent Patient Share in Europe, According to a New Report from Decision Resources WALTHAM, Mass., March 11 /PRNewswire/ -- Decision Resources, one of the world's leading research and adviso...

Merck Announces Plans for Licensing Atripla Widely in Developing World

Merck & Co is seeking to register its three-in-one fixed dose combination Atripla in 66 developing countries, in addition to seeking// World Health Organization prequalification for the product, the company announced on Friday. Atripla, which is a single tablet containing a daily dose of efa...

Sales of Antiretroviral Agents Will Drive Substantial Six Percent Annual Growth in the HIV Drug Market Through 2013

...an. The new Pharmacor report entitled Human Immunodeficiency Virus finds that continued increase in the uptake of Bristol-Myers Squibb/Gilead's atripla will drive the agent to garner the highest sales of any antiretroviral in 2013. However, from 2013 to 2018, Gilead's Quad will make significant inroad...
Atripla in Medical Technology

European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection

...ir disoproxil fumarate 300 mg), formally approving atripla for commercialization in the 27 countries of the E...mportant step forward in dosing simplification." atripla has been approved in the European Union for the tr...apy. The marketing authorization application for atripla in the European Union was filed by a three-way joi...

Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe

... approval by the European Commission. If approved, atripla would represent the first and only once-daily sing...nd Gilead share responsibility for commercializing atripla throughout the European Union and certain other Eu...lead will record revenues from future net sales of atripla in most of the European countries, while Bristol-M...

European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)

... - Once Granted by the European Commission, atripla Would Represent the First and Only Once-Daily Sin...te 300 mg). Specifically, the CHMP has recommended atripla for the treatment of human immunodeficiency virus-...stance to any of the three components contained in atripla prior to initiation of their first antiretroviral ...

Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV

...fection in adults. With this Notice of Compliance, atripla becomes the first once-daily single tablet regimen...apy or in combination with other antiretrovirals. atripla combines SUSTIVA(R) (efavirenz), manufactured by B... three-drug regimen in a single once-daily pill." atripla was developed through a joint venture partnership ...

Merck/Gilead Once-A-Day AIDS Pill Not Available in Most Places - AHF Urges Speed-Up of Registrations

...once daily lifesaving HIV treatment, Atripla, in developing countries. When atripla first received approval from the Food and Drug Administration (FDA) in July... 2006. Efforts made by AHF to clarify what countries currently can purchase atripla at the announced $613 per patient per year access price have gone unanswere...
Other Tags
(Date:4/22/2014)... are more likely to have a child who develops ... A recent study from researchers from the Drexel University ... in Sweden provides more insight into how the risk ... ages, and found that the risk of having a ... for older parents., In the study, published in the ...
(Date:4/22/2014)... Based on results of a clinical trial led ... and Drug Administration (FDA) approved a molecularly targeted ... that has progressed after standard chemotherapy has failed. ... was announced by the manufacturer, Lilly Oncology, of ... ramucirumab, it will be sold under the name ...
(Date:4/22/2014)... identify patients who are at highest risk for respiratory ... condition, suggest data from a large multi-center study published ... Affecting nearly 200,000 Americans a year, acute respiratory distress ... caused by a number of issues ranging from smoke ... develop ARDS after surgery. ARDS is difficult to treat ...
(Date:4/22/2014)... out of the University of Calgary,s Hotchkiss Brain Institute ... nerve cells as a means to restore connections after ... a key molecule that directly regulates nerve cell growth ... in the prestigious journal Nature Communications , with ... "We made the surprising discovery that a protein ...
(Date:4/21/2014)... ROCHESTER, Minn. Acute respiratory distress syndrome is ... Patients who develop the lung disorder postoperatively are ... and those who survive the syndrome may still ... A Mayo Clinic-led study is helping physicians better ... toward preventing this dangerous and costly surgical complication. ...
Breaking Medicine News(10 mins):Health News:Child's autism risk accelerates with mother's age over 30 2Health News:Child's autism risk accelerates with mother's age over 30 3Health News:FDA approves first targeted drug for advanced stomach cancer 2Health News:New tool helps doctors better predict, prevent deadly respiratory failure 2Health News:Scientists discover a new way to enhance nerve growth following injury 2Health News:Acute respiratory distress syndrome: Study IDs surgical patients at risk 2
(Date:4/22/2014)... from NeuroPhage Pharmaceuticals, Inc. have engineered a series ... neurodegenerative diseases that are characterized by misfolded proteins, ... molecules are based on what the Company calls ... recognizes a characteristic common to many toxic, misfolded ... This approach provides NeuroPhage with an array of ...
(Date:4/22/2014)... activity of babies in developing countries could be ... of cognitive dysfunction, using a new technique piloted ... function of infants can be visualised and tracked ... the method, called functional near infra-red spectroscopy (fNIRS), ... relied upon for decades. , Professor Clare ...
(Date:4/21/2014)... 21, 2014 Performing brain research that can one ... of Houston (UH) junior Khanh (Kate) Nguyen has been ... A double major in mathematics and physics, Nguyen is ... Scholarship. , One of the most prestigious awards ... to sophomore and junior students majoring in mathematics, the ...
Breaking Biology News(10 mins):NeuroPhage discovers GAIM-changing molecules to combat Alzheimer's and related diseases 2NeuroPhage discovers GAIM-changing molecules to combat Alzheimer's and related diseases 3First brain images of African infants enable research into cognitive effects of nutrition 2UH student named Goldwater Scholar, 2 more receive honorable mention 2UH student named Goldwater Scholar, 2 more receive honorable mention 3UH student named Goldwater Scholar, 2 more receive honorable mention 4
Other Contents